Success involves risk
October 25, 2009 by Tucker
It is no small endeavour to create a new business. Especially if you are creating a new business that is going to be manufacturing a new product.
Success can be agonizing difficult to achieve . But usually it favours the careful who are prudent in their choices. Tahitian Noni International having begun in 1996 has corporate leadership that is no stranger to start-up company risks. The original idea of manufacturing and selling Noni juice through a network marketing business had never been done before. The rather revolutionary compensation plan they invented where 53% was paid back to independent product consultants was also unheard of before. Never the less the five founders pressed ahead and soon found that they have been correct in judging the Noni business opportunity. Rapid growth has been the norm since 1996 with sky rocketing sales.
Joining a network marketing organization will give you a full business opportunity with less risk and a simpler job to do. You find new customers and introduce them to the products and the company does the rest. We have chosen Tahitian Noni International as our network marketing. We did this simply because we do the finding of customers and they really do all the rest. Product development, advertising, order taking and shipping are expertly done worldwide. The only thing we concern ourselves with is finding more customers every day and introducing them to the products and the business opportunity. Earn more money . Tahitian Noni International Noni products are transforming Lives with Industry – Leading Payout: TNI pays a 53% commission including worldwide bonus pools. Noni is our main ingredient and Noni Juice our main product.
As indicated at the bottom of all our web pages, these statements have not been evaluated by the Food and Drug Administration and these products are not intended to diagnose, treat, cure, or prevent any disease. Our website has the details and ordering information for our Noni Products.
PROVO, Utah, April 8 /PRNewswire/ — Tahitian Noni International (TNI) now has 14 human clinical studies that prove the efficacy of their bioactive beverages — and more are on the way. TNI has more human clinical studies than any network marketing superfruit company and strongly believes in backing
Nice video and Tahitian Noni offers great products.
Right so I don’t think it was the manufactures fault.. I think the peanuts were bad because they are genetically altered. To keep things quiet they blame it on a rodent problem.. At least try to look outside the box. One day alot of people are gonna get sick because of these genetically modified seeds or worse and the FDA is probably gonna blame it in on something else since they approved it. This is so frustrating.
I was reading something and I found something really…retarded…it said that the FDA states that “Only drugs can cure, prevent, or treat diseases.” so this helps the drug companies and this also means that if you got an orange, said it cured scurvvy, because of Vitamin C content, you would be sent to jail for selling a “drug”, because drugs can only treat and cure diseases and now bye cuz you’re without a license. What the holy hell of a hockey stick is wrong with this picture?
Tahitian Noni International Wins Grand Slam with Paul Haarhuis
tahitiannonisite.com TAHITIAN NONI Pure are new Noni Juices.Amazing.: Recently Tahitian Noni International upgraded their line of Noni… -
Yes, antibiotic use in livestock is a troubling issue and is very controversial. The Food and Drug Administration (FDA), as well as the CDC and other organizations are taking actions to reduce this problem, but it will take time. One way the FDA helps to reduce antimicrobial use in livestock is that the “FDA prohibits the extra-label use of certain important human antimicrobials when they are used in food-producing animals. Fluoroquinolones, for example, may be used only according to the specific label directions for which they were approved.” This means that if the label of an antibiotic drug, such as Flouroquinolones, states that it is only to be used to treat an infection, than that product may only be used to treat an infection in an animal and not, for instance, added to animal feed for the purpose of weight gain.
Source:
Henney, Jane M.D. and Wotecki, Catherine Ph.D., R.D. (2000). Antibiotic Resistance in Livestock. Food and Drug Administration.
http://www.fda.gov/downloads/AnimalVeterinary/SafetyHealth/AntimicrobialResistance/UCM134733.pdf
i'm certain this figure represents only a small fraction of the deaths.
YES!!!!!!! I'm willing to pay outrageous prices for products produced in the U.S.
Detoxifying Diet ..->>> Tahitian Noni International Releases New Fit Reduce Tahitian Noni International Releases New Bioactive Cleanse Beverage <<< >>>
Tahitian Noni Juice Original: http://www.tni.com/3052783 E-mail:
"Orphan Drug" status and "Fast Track" designations generally mean the drug will be moved to the open market faster.
"Fast tracking" is allowed by the FDA when drugs in their experimental trial phase vastly exceed expectations and/or the drug works so much better than placebo in the drug's experimental trials that those getting placebo are clearly worse off (that it would be inhumane to give them placebo when the alternative works so much better).
The FDA's drug approval process usually takes many years, and "fast tracking" shortens that time considerably.
So the advantages to fast tracking are:
1. to the drug manufacturer because they have longer patent time to sell the drug without competition
2. to the patients in the general public (who are not in the experimental phase of the drug already) who may potentially need these drugs because they can get their hands on them sooner
3. investors in such drug companies as news like this often causes their stock prices to jump
The major disadvantage is that researchers and the FDA are more likely to overlook rare side effects or other adverse drug events (think Vioxx) that have been rare enough that only time will expose them.
"Orphan drug" status I don't think is as desirable. Orphan drugs are technically drugs that are required but its use will be relatively infrequent (so it's not gonna be a big money-maker). To make this easier to understand, let us say that company XYZ comes up with a drug that treats condition/disease ABC. However, condition ABC only affects, say 50,000 people. It is a legitimate disease, but it is unlikely company XYZ will profit from making the drug to treat this condition ABC. Most companies are truly in business only to make money, so company XYZ really has no reason to produce this drug because it won't make them any money. But what about the 50,000 people who have this disease? Will they be forced to suffer, even though a cure exists? So what the FDA does to remedy this problem is grant company XYZ's drug "orphan drug" status so that it has exclusive patent rights to this drug, AND probably pays the company some kind of grant money or something so that it will offset the losses that XYZ would incur by producing this non-moneymaking drug.
That label is on every energy drink. It just means that the energy drink is not approved to treat any illness you have. It's safe to drink and if it wasn't the FDA would pull it from the shelves.
Tahitian Noni International Training – Can You Still Make Money With Noni? -
Der Flavon max Verbraucherklub. Neue Wege.
training training training Tahitian Noni International Jakarta) -
posted by: Dr.Prahallad Panda remarks: Zilpidem quickly indices sleep, so helpful for those who wake up after a short sleep at night. Researchers say ABCC9 gene is responsible for short sleep at night. Amplify’d from yourlife.usatoday.com Insomnia drug for middle of the night wakers approved by FDA The first insomnia drug for people who wake in the middle of the night and then have trouble getting back to sleep has been approved by the U.S. Food and Drug Administration. EnlargeClose Intermezzo (zolpidem tartrate sublingual tablets) should only be used when a person has at least four hours of bedtime remaining and should not be taken with any other sleep aids or if a person had consumed alcohol, the FDA said. The recommended and maximum doses are 3.5 milligrams for men and 1.75 mg for women, taken once per night. The dose is lower for women because their bodies take longer to clear the drug. The approval was based on two clinical trials involving more than 370 patients. Patients who…
I know someone who sells it. Apparently it is supposed to help your health, but I'd rather be unhealthy than drink that stuff everyday. It tasted disgusting.